regulation is the sole category represented across all 1 tracked stories. Candida auris is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Trichophyton indotineae appears in 1 tracked Cross-Sector story from February 27, 2026. The tracked stories average 2 original sources each.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Trichophyton indotineae
regulation is the sole category represented across all 1 tracked stories. Candida auris is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Trichophyton indotineae appears in 1 tracked Cross-Sector story from February 27, 2026. The tracked stories average 2 original sources each.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Trichophyton indotineae. Shared-story counts are live from our verified record — not editorial picks.
New York health officials have issued a high-priority alert regarding the rapid spread of highly drug-resistant fungal infections across the state's healthcare infrastructure. These pathogens, including Candida auris, pose a severe threat to immunocompromised patients and are increasingly evading standard antifungal treatments.